Works by Suenaga, Yusuke

Results: 23

The Combination of Sorafenib and PGV‐1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c‐Myc Suppression in an Additive Manner: In Vitro Studies.

Published in:

Advances in Pharmacological & Pharmaceutical Sciences, 2024, v. 2024, p. 1, doi. 10.1155/adpp/4297953

By:

Novitasari, Dhania;
Nakamae, Ikuko;
Yoneda-Kato, Noriko;
Kato, Jun-ya;
Hippo, Yoshitaka;
Suenaga, Yusuke;
Putri, Dyaningtyas Dewi Pamungkas;
Meiyanto, Edy;
Ikawati, Muthi';
Ooi, Der Jiun

Publication type:

Article

De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.

Published in:

Japanese Journal of Clinical Oncology, 2020, v. 50, n. 8, p. 839, doi. 10.1093/jjco/hyaa097

By:

Suenaga, Yusuke;
Nakatani, Kazuma;
Nakagawara, Akira

Publication type:

Article

Pentagamavunone-1 Suppresses MYCN-Positive HuH-7 Cancer Cell Growth Via Mitotic Arrest In Vitro.

Published in:

Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia, 2024, v. 35, n. 4, p. 649

By:

Moordiani;
Novitasari, Dhania;
Susidarti, Ratna Asmah;
Ikawati, Muthi';
Kato, Jun-Ya;
Hippo, Yoshitaka;
Suenaga, Yusuke;
Meiyanto, Edy

Publication type:

Article

Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.

Published in:

Genes to Cells, 2009, v. 14, n. 12, p. 1429, doi. 10.1111/j.1365-2443.2009.01359.x

By:

Okoshi, Rintaro;
Ando, Kiyohiro;
Suenaga, Yusuke;
Sang, Meixiang;
Kubo, Natsumi;
Kizaki, Harutoshi;
Nakagawara, Akira;
Ozaki, Toshinori

Publication type:

Article

Sp1-mediated transcriptional regulation of NFBD1/MDC1 plays a critical role in DNA damage response pathway.

Published in:

Genes to Cells, 2008, v. 13, n. 1, p. 53, doi. 10.1111/j.1365-2443.2007.01144.x

By:

Bu, Youquan;
Suenaga, Yusuke;
Ono, Sayaka;
Koda, Tadayuki;
Song, Fangzhou;
Nakagawara, Akira;
Ozaki, Toshinori

Publication type:

Article

Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation.

Published in:

Oncology Reports, 2025, v. 53, n. 4, p. N.PAG, doi. 10.3892/or.2025.8880

By:

Tatsumi, Yasutoshi;
Masuda, Tatsuya;
Watanabe, Takayoshi;
Utomo, Rohmad Yudi;
Zulfin, Ummi Maryam;
Meiyanto, Edy;
Ozaki, Toshinori;
Suenaga, Yusuke;
Kamikubo, Yasuhiko

Publication type:

Article

Open reading frame dominance indicates protein‐coding potential of RNAs.

Published in:

EMBO Reports, 2022, v. 23, n. 6, p. 1, doi. 10.15252/embr.202154321

By:

Suenaga, Yusuke;
Kato, Mamoru;
Nagai, Momoko;
Nakatani, Kazuma;
Kogashi, Hiroyuki;
Kobatake, Miho;
Makino, Takashi

Publication type:

Article

ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma.

Published in:

Scientific Reports, 2013, p. 1, doi. 10.1038/srep03450

By:

Hasan, Md. Kamrul;
Asmaa Nafady;
Atsushi Takatori;
Satoshi Kishida;
Miki Ohira;
Yusuke Suenaga;
Shamim Hossain;
Jesmin Akter;
Atsushi Ogura;
Yohko Nakamura;
Kenji Kadomatsu;
Akira Nakagawara

Publication type:

Article

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 587, doi. 10.1111/cas.15205

By:

Ando, Kiyohiro;
Ohira, Miki;
Takada, Ichiro;
Cázares‐Ordoñez, Verna;
Suenaga, Yusuke;
Nagase, Hiroki;
Kobayashi, Shinichi;
Koshinaga, Tsugumichi;
Kamijo, Takehiko;
Makishima, Makoto;
Wada, Satoshi

Publication type:

Article

Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.

Published in:

Cancer Science, 2015, v. 106, n. 10, p. 1351, doi. 10.1111/cas.12746

By:

Islam, S. M. Rafiqul;
Suenaga, Yusuke;
Takatori, Atsushi;
Ueda, Yasuji;
Kaneko, Yoshiki;
Kawana, Hidetada;
Itami, Makiko;
Ohira, Miki;
Yokoi, Sana;
Nakagawara, Akira

Publication type:

Article

Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas.

Published in:

Cancer Science, 2015, v. 106, n. 7, p. 840, doi. 10.1111/cas.12677

By:

Kaneko, Yoshiki;
Suenaga, Yusuke;
Islam, S. M. Rafiqul;
Matsumoto, Daisuke;
Nakamura, Yohko;
Ohira, Miki;
Yokoi, Sana;
Nakagawara, Akira

Publication type:

Article

1H, 13C and 15N backbone and side-chain resonance assignments of the human oncogenic protein NCYM.

Published in:

Biomolecular NMR Assignments, 2024, v. 18, n. 1, p. 65, doi. 10.1007/s12104-024-10169-3

By:

Mouhand, Assia;
Nakatani, Kazuma;
Kono, Fumiaki;
Hippo, Yoshitaka;
Matsuo, Tatsuhito;
Barthe, Philippe;
Peters, Judith;
Suenaga, Yusuke;
Tamada, Taro;
Roumestand, Christian

Publication type:

Article

Inhibition of OCT4 binding at the MYCN locus induces neuroblastoma cell death accompanied by downregulation of transcripts with high-open reading frame dominance.

Published in:

Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1237378

By:

Kazuma Nakatani;
Hiroyuki Kogashi;
Takanori Miyamoto;
Taiki Setoguchi;
Tetsushi Sakuma;
Kazuto Kugou;
Yoshinori Hasegawa;
Takashi Yamamoto;
Yoshitaka Hippo;
Yusuke Suenaga

Publication type:

Article

Structural characterization of human de novo protein NCYM and its complex with a newly identified DNA aptamer using atomic force microscopy and small-angle X-ray scattering.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1213678

By:

Seigi Yamamoto;
Fumiaki Kono;
Kazuma Nakatani;
Miwako Hirose;
Katsunori Horii;
Yoshitaka Hippo;
Taro Tamada;
Yusuke Suenaga;
Tatsuhito Matsuo

Publication type:

Article

DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN -Amplified Neuroblastoma IMR32 Cells.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 9012, doi. 10.3390/ijms24109012

By:

Ando, Kiyohiro;
Suenaga, Yusuke;
Kamijo, Takehiko

Publication type:

Article

MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung.

Published in:

Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33696-1

By:

Xia, Endi;
Kanematsu, Sotaro;
Suenaga, Yusuke;
Elzawahry, Asmaa;
Kondo, Hitomi;
Otsuka, Noriko;
Moriya, Yasumitsu;
Iizasa, Toshihiko;
Kato, Mamoru;
Yoshino, Ichiro;
Yokoi, Sana

Publication type:

Article

PGV-1 Causes Disarrangement of Spindle Microtubule Organization Resulting in Aberrant Mitosis in HLF and HuH6 Cells Associated with Altered MYCN Status.

Published in:

Advanced Pharmaceutical Bulletin, 2024, v. 14, n. 3, p. 665, doi. 10.34172/apb.2024.058

By:

Nugraheni, Nadzifa;
Zulfin, Ummi Maryam;
Lestari, Beni;
Hapsari, Novia Permata;
Ikawati, Muthi;
Utomo, Rohmad Yudi;
Suenaga, Yusuke;
Hippo, Yoshitaka;
Meiyanto, Edy

Publication type:

Article

Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.

Published in:

International Journal of Cancer, 2008, v. 123, n. 9, p. 2087, doi. 10.1002/ijc.23776

By:

Ando, Kiyohiro;
Ohira, Miki;
Ozaki, Toshinori;
Nakagawa, Atsuko;
Akazawa, Kohei;
Suenaga, Yusuke;
Nakamura, Yohko;
Koda, Tadayuki;
Kamijo, Takehiko;
Murakami, Yoshinori;
Nakagawara, Akira

Publication type:

Article

NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas.

Published in:

PLoS Genetics, 2014, v. 10, n. 1, p. 1, doi. 10.1371/journal.pgen.1003996

By:

Suenaga, Yusuke;
Islam, S. M. Rafiqul;
Alagu, Jennifer;
Kaneko, Yoshiki;
Kato, Mamoru;
Tanaka, Yukichi;
Kawana, Hidetada;
Hossain, Shamim;
Matsumoto, Daisuke;
Yamamoto, Mami;
Shoji, Wataru;
Itami, Makiko;
Shibata, Tatsuhiro;
Nakamura, Yohko;
Ohira, Miki;
Haraguchi, Seiki;
Takatori, Atsushi;
Nakagawara, Akira

Publication type:

Article

Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.861963

By:

Ando, Kiyohiro;
Sanda, Takaomi;
Suenaga, Yusuke;
Liu, Tao

Publication type:

Article

Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.803443

By:

Suenaga, Yusuke;
Einvik, Christer;
Takatori, Atsushi;
Zhu, Yuyan

Publication type:

Article

Secondary Structure of Human De Novo Evolved Gene Product NCYM Analyzed by Vacuum-Ultraviolet Circular Dichroism.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.688852

By:

Matsuo, Tatsuhito;
Nakatani, Kazuma;
Setoguchi, Taiki;
Matsuo, Koichi;
Tamada, Taro;
Suenaga, Yusuke

Publication type:

Article

A high-throughput screening platform to identify MYCN expression inhibitors for liver cancer therapy.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1486671

By:

Xu, Yali;
Mishra, Hricha;
Furutani, Yutaka;
Yanaka, Kaori;
Nishimura, Hajime;
Furuhata, Erina;
Takahashi, Masataka;
Gailhouste, Luc;
Suenaga, Yusuke;
Hippo, Yoshitaka;
Yu, Wenkui;
Matsuura, Tomokazu;
Suzuki, Harukazu;
Qin, Xian-Yang

Publication type:

Article

Works by Suenaga, Yusuke

The Combination of Sorafenib and PGV‐1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c‐Myc Suppression in an Additive Manner: In Vitro Studies.

De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.

Pentagamavunone-1 Suppresses MYCN-Positive HuH-7 Cancer Cell Growth Via Mitotic Arrest In Vitro.

Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.

Sp1-mediated transcriptional regulation of NFBD1/MDC1 plays a critical role in DNA damage response pathway.

Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation.

Open reading frame dominance indicates protein‐coding potential of RNAs.

ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma.

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis.

Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.

Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas.

<sup>1</sup>H, <sup>13</sup>C and <sup>15</sup>N backbone and side-chain resonance assignments of the human oncogenic protein NCYM.

Inhibition of OCT4 binding at the MYCN locus induces neuroblastoma cell death accompanied by downregulation of transcripts with high-open reading frame dominance.

Structural characterization of human de novo protein NCYM and its complex with a newly identified DNA aptamer using atomic force microscopy and small-angle X-ray scattering.

DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN -Amplified Neuroblastoma IMR32 Cells.

MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung.

PGV-1 Causes Disarrangement of Spindle Microtubule Organization Resulting in Aberrant Mitosis in HLF and HuH6 Cells Associated with Altered MYCN Status.

Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.

<i>NCYM</i>, a <i>Cis</i>-Antisense Gene of <i>MYCN</i>, Encodes a <i>De Novo</i> Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas.

Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials.

Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors.

Secondary Structure of Human De Novo Evolved Gene Product NCYM Analyzed by Vacuum-Ultraviolet Circular Dichroism.

A high-throughput screening platform to identify MYCN expression inhibitors for liver cancer therapy.